Amylyx Pharmaceuticals, Inc.

8-K Shareholder vote results Jun 4, 2026 10-Q Quarter ended 2026-03-31 May 7, 2026 8-K Results of operations (earnings release) May 7, 2026 8-K Regulation FD disclosure Mar 24, 2026 10-K Fiscal year ended 2025-12-31 Mar 3, 2026 8-K Results of operations (earnings release) Mar 3, 2026 8-K Regulation FD disclosure; Other events Jan 8, 2026 10-Q Quarter ended 2025-09-30 Nov 6, 2025 8-K Results of operations (earnings release) Nov 6, 2025 8-K Entered a material agreement Sep 10, 2025 8-K Other events Aug 27, 2025 10-Q Quarter ended 2025-06-30 Aug 7, 2025 8-K Results of operations (earnings release) Aug 7, 2025 8-K Shareholder vote results Jun 5, 2025 10-Q Quarter ended 2025-03-31 May 8, 2025 8-K Results of operations (earnings release) May 8, 2025 10-K Fiscal year ended 2024-12-31 Mar 4, 2025 8-K Results of operations (earnings release) Mar 4, 2025 8-K Entered a material agreement Jan 10, 2025 8-K Regulation FD disclosure Dec 30, 2024 10-Q Quarter ended 2024-09-30 Nov 7, 2024 8-K Results of operations (earnings release) Nov 7, 2024 8-K Other events Oct 17, 2024 10-Q Quarter ended 2024-06-30 Aug 8, 2024 8-K Results of operations (earnings release) Aug 8, 2024 8-K Completed an acquisition or disposition Jul 10, 2024 8-K Entered a material agreement Jun 21, 2024 8-K Shareholder vote results Jun 6, 2024 10-Q Quarter ended 2024-03-31 May 9, 2024 8-K Results of operations (earnings release) May 9, 2024 8-K Other events Apr 10, 2024 8-K Exit or disposal costs; Regulation FD disclosure; Other events Apr 4, 2024 8-K Director or officer change Mar 14, 2024 8-K Regulation FD disclosure; Other events Mar 8, 2024 10-K Fiscal year ended 2023-12-31 Feb 22, 2024 8-K Results of operations (earnings release) Feb 22, 2024 8-K Regulation FD disclosure Dec 7, 2023 10-Q Quarter ended 2023-09-30 Nov 9, 2023 8-K Results of operations (earnings release) Nov 9, 2023 8-K Other events Oct 13, 2023